Jupiter Neurosciences (JUNS) Operating Expenses (2023 - 2026)

Jupiter Neurosciences (JUNS) has reported Operating Expenses for 4 consecutive years, with $2.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Expenses rose 22.04% year-over-year to $2.8 million in Q2 2026; TTM through Jun 2026 was $10.2 million, a 76.41% increase from a year earlier, with the FY2025 full-year figure at $8.9 million, up 188.76% from the prior year.
• Operating Expenses was $2.8 million for Q2 2026 at Jupiter Neurosciences, down from $2.8 million in the prior quarter.
• Over five years, Operating Expenses peaked at $2.8 million in Q4 2025 and troughed at $493547.0 in Q3 2024.
• A 4-year average of $1.5 million and a median of $1.5 million in 2024 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses tumbled 65.78% in 2024 and soared 365.42% in 2025, its largest moves.
• Over 4 years, Operating Expenses stood at $535642.0 in 2023, then soared by 172.26% to $1.5 million in 2024, then soared by 93.8% to $2.8 million in 2025, then declined by 2.21% to $2.8 million in 2026.
• The last three Operating Expenses figures came in at $2.8 million (Q2 2026), $2.8 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.